Dna X (SONM) Depreciation & Amortization (CF) (2018 - 2025)

Dna X has reported Depreciation & Amortization (CF) for 8 years, with the latest figure at $1.5 million in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 63.68% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 13.05% YoY), and the FY2025 full-year result was $4.3 million, up 20.89% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $1.5 million, up from $952000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.8 million in Q4 2022, with the low at $67000.0 in Q3 2023.
• Historically, Depreciation & Amortization (CF) has averaged $728350.0 across 5 years, with a median of $713500.0 in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) plunged 71.84% — and 2024, when it soared 1270.15%.
• Dna X's Depreciation & Amortization (CF) stood at $498000.0 in 2021, then surged by 265.46% to $1.8 million in 2022, then slumped by 47.47% to $956000.0 in 2023, then declined by 4.39% to $914000.0 in 2024, then surged by 63.68% to $1.5 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $1.5 million (Q4 2025), $952000.0 (Q3 2025), and $797000.0 (Q2 2025), per Business Quant data.